Skip to main content

Table 1 Baseline of normal healthy and ERSD patients

From: RETRACTED ARTICLE: Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging

 

Normal (n = 25)

ERSD(n = 66)

Age(Y)

51.21 ± 6.06

55.10 ± 15.83

Male (n, %)

9 (36.00%)

25 (37.87%)

Weight (kg)

57.83 ± 8.45

58.01 ± 11.29

Height (cm)

160.70 ± 6.39

158.93 ± 8.47

BMI (kg/m2)

24.02 ± 2.53

22.75 ± 3.61

BSA(m2)

1.52 ± 0.13

1.56 ± 0.178

Systolic blood pressure (mmHg)

117.25 ± 13.48

141.45 ± 23.45

Diastolic blood pressure (mmHg)

70.69 ± 19.17

86.84 ± 16.05

HR (beats/min)

72.35 ± 21.66

81.81 ± 14.38

During of CKD

3 month-20 year

During of dialysis

3 month-11 year

Occurrence of HF (n, %)

25 (37.87%)

Causes of ESRD

 Polycystic kidney disease (n, %)

16 (24.24%)

 Primary glomerular nephropathy (n, %)

35 (53.03%)

 Vasculitis (n, %)

3 (4.54%)

 Genitourinary tuberculosis (n, %)

2 (3.03%)

 Ureteral tumor (n, %)

1 (1.51%)

 Primary hypertension

9 (13.64%)

The biochemical measurements

 eGFR (ml/min/1.732 m2) (normal range 80-120 ml/min/1.72 m2)

6.35 ± 2.77

 Urea (mmol/l) (normal range 3.30–8.22)*

909.00 (651.00–1052.25)

 Uric acid (umol/l) (normal range 240.0–490.0)

432.63 ± 147.28

 Creatinine (umol/l) (normal range53.0–140.0)

824.07 ± 290.44

 Hct (L/L) (normal range0.40–0.50)

0.34 ± 0.06

 PTH (pmol/l) (normal range 1.6–6.9) *

33.55 (21.62, 73.245)

 Hb(g/l) (male 120–160; female110–150)

102.15 ± 26.72

Blood pressure Medications

 Angiotensin converting enzyme inhibitor or angiotensin receptor blocker diuretic

25 (37.88%)

 Calcium channel blocker

38 (57.57%)

 ɑ blocker

15 (46.88%)

 β blocker

10 (15.16%)

  1. Values are mean ± SD, median(quartile) or n (%). * means the data is not conformed with normal distribution and presented as median (quartile). BMI Body mass index, BSA body surface area, HR heart rate, ESRD End-stage renal disease, CKD chronic kidney disease, eGFR estimated Glomerular Filtration Rate, Hb hemoglobin, Hct hematocrit, PTH parathyroid hormone